Evidence map›Paper›PMID 37534098›Full record

ArticleJournal of clinical biochemistry and nutrition2023

Quenching effect of cerium oxide nanoparticles on singlet oxygen: validation of the potential for reaction with multiple reactive oxygen species.

Yukihiro Ogawa, Tsunetaka Kawaguchi, Mami Tanaka, Akiko Hashimoto, Koji Fukui, Naofumi Uekawa, Toshihiko Ozawa, Toshiaki Kamachi, Masahiro Kohno

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical biochemistry and nutrition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Yukihiro OgawaApplause Company Limited, Biko-building 4F, 2-24-2, Shinkawa, Chuo-ku, Tokyo 104-0033, Japan.
Tsunetaka KawaguchiApplause Company Limited, Biko-building 4F, 2-24-2, Shinkawa, Chuo-ku, Tokyo 104-0033, Japan.
Mami TanakaApplause Company Limited, Biko-building 4F, 2-24-2, Shinkawa, Chuo-ku, Tokyo 104-0033, Japan.
Akiko HashimotoApplause Company Limited, Biko-building 4F, 2-24-2, Shinkawa, Chuo-ku, Tokyo 104-0033, Japan.
Koji FukuiMolecular Cell Biology Laboratory, Department of Bioscience and Engineering, College of System Engineering and Science, Shibaura Institute of Technology, Fukasaku 307, Minuma-ku, Saitama 337-8570, Japan.
Naofumi UekawaGraduate School of Engineering, Chiba University, 1-33 Yayoi-chou, Image-ku, Chiba-shi, Chiba 263-8522, Japan.
Toshihiko OzawaSchool of Pharmaceutical Sciences, Nihon Pharmaceutical University, 10281 Komuro, lna-machi, Kitaadachi-gun, Saitama 362-0806, Japan.
Toshiaki KamachiSchool of Life Science and Technology, Tokyo Institute of Technology, 2-12-1 Ookayama, Meguro-ku, Tokyo 152-8550, Japan.
Masahiro KohnoSchool of Life Science and Technology, Tokyo Institute of Technology, 2-12-1 Ookayama, Meguro-ku, Tokyo 152-8550, Japan.
Tokyo Institute of Technology · JPChiba University · JPNihon Pharmaceutical University · JPShibaura Institute of Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here we studied cerium oxide nanoparticles (nanoceria) as an agent for the future treatment of oxidative damage by validating and evaluating its scavenging activity towards reactive oxygen species (ROS)

Indexed as

antioxidantcerium oxide nanoparticleselectron paramagnetic resonancereactive oxygen speciessinglet oxygen

Identifiers

PMID37534098
PMCPMC10390806
OpenAlexW4378974818

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.